1st Quarter - Report

AVENUE SOLUTIONS for MERCK & CO. INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues relating to the further development of antibiotics and antimicrobials for serious and unmet medical needs; Antibiotics/stewardship; S. 1712, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; Value of prescription drugs; Issues related to Medicare Parts B and D; Biosimilars policies; Medicaid AMP (Average Manufacturer Price) cap; S. 2543, Prescription Drug Pricing Reduction Act of 2019

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2543 (116th), S. 1712 (116th)

Health Issues HCR

Antibiotics/stewardship; Value of prescription drugs; Issues related to Title X and women's preventative health services; S. 1712, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; H.R. 4100, DISARM Act of 2019; H.R. 748 (Public Law 116-136), CARES Act

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 748 (116th), H.R. 4100 (116th), S. 1712 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.